Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia-Reference-Cited by-同舟云学术

Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophrenia

Published:2024-03-25 Issue:4 Volume:23 Page:399-409
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ward Kristen¹^ORCID,Citrome Leslie²^ORCID

Affiliation:

1. Clinical Pharmacy Department, University of Michigan College of Pharmacy, Ann Arbor, MI, USA

2. Department of Psychiatry and Behavioral Science, New York Medical College, Valhalla, NY, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2328812

Reference118 articles.

1. World Health Organization. Schizophrenia. 2022 [cited 2023 27 Jun]. Available from: https://www.who.int/news-room/fact-sheets/detail/schizophrenia.

2. A Systematic Review and Meta-Analysis of Recovery in Schizophrenia

3. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016

4. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

5. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia;Biomolecules;2024-07-25

2. Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment;Clinical Drug Investigation;2024-06-21